The CDA annual conference will feature 67 e-posters this year. Selected for quality and merit, e-posters can be viewed from terminals located on Level 2 of the Fredericton Convention Centre (Pointe Sainte-Anne Foyer) and will be available as follows:

  • June 21: 12pm – 5pm
  • June 22: 8am – 6pm
  • June 23: 8am – 5:30pm
  • June 24: 8am – 2pm

Twenty e-posters will also be presented live by the authors on Thursday from 1pm to 2:20pm at two poster stations located in the exhibit hall.

e-Poster live presentation schedule

If you would like to recognize the work of a colleague, please nominate them for the CDA Best Scientific Poster Award.

The CDA Best Scientific Poster Award is presented to the author whose poster received the highest number of nominations.  Announcement and presentation of a Certificate of Recognition will take place Saturday evening at the CDA Awards Ceremony.

More than one colleague may be nominated. Nominations close Saturday at 1 pm AT.


Stand-By Posters

P01.01 Chronic Actinic Dermatitis Results in a Police Takedown: An Instrumental Case Study Huang, Christina M.
P01.02 Cost as a barrier to using sunscreen as a sun protection measure Hudson, Alexandra
P01.03 A Systematic Review of the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: Time for Change? Mansour, Danny
P01.04 The 20/20 Optics of Hidradenitis Suppurativa Brown-Maher, Tracey
P01.05 Kawasaki Disease Masked by Pustular Type Psoriasiform Eruptions: A Case Report Hassani-Ardakani, Kimya
P01.06 Hypersensitivity to mosquito bites associated with EBV infection and suspected immunodeficiency Kadlubowska, Dorota
P01.07 Occupational Stress of Anesthesia: Effects on Skin Aging and Telomere length Abdelmaksoud, Rania E.
P01.08 Somatic Mutations Analysis in Circumscribed Palmoplantar Hypokeratosis Basseri, Sana
P01.09 Efficacy and Safety of Secukinumab in Treating Moderate to Severe Plaque Psoriasis in Two Academic Dermatology Clinics: a Multicenter Retrospective Study Georgakopoulos, Jorge C.
P01.10 A showcase of the revised hair pull test range and new pre-test guidelines McDonald, Katherine A.
P02.01 Comparison of the Treatment Guidelines for Actinic Keratoses: A Critical Appraisal and Review Zhou, Stephanie
P02.02 Current Practice of Canadian Dermatologists for the Field Therapy of Actinic Keratoses Sarwar, Zaini
P02.03 Looking at your future: Appearance-based interventions and skin cancer prevention Spurr, Alison C.
P02.04 Tumeur à cellules de Merkel agressive au site chirurgical d’un carcinome basocellulaire traité par chirurgie micrographique de Mohs et radiothérapie Laroche, Alexandre
P02.05 A Cross-Sectional Study of Indoor Tanning in Fitness Centres Huang, Christina M.
P02.06 PURE Study design and update: A new registry of Patients with moderate to severe chronic plaqUe psoRiasis in Canada and Latin AmErica Gooderham, Melinda
P02.07 Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids up to 1 year: a phase 3 trial (CHRONOS) Gooderham, Melinda
P02.08 Biologics Persistency in the Real-World Setting Mayba, Julia
P02.09 OBSERVE-5 sub-analysis: 5-year etanercept safety results for the treatment of psoriasis in Canada vs the United States Papp, Kim
P02.10 Effectiveness of Systemic Treatments for Pyoderma Gangrenosum: A Systematic Review of Observational Studies & Clinical Trials Partridge, Arun C.

View Only Posters

P03.01 Photoprotection in the immunosuppressed pediatric population Zarins, Andrea J.
P03.02 An update on the use of alitretinoin for chronic hand dermatitis in a dermatology practice setting Crowley, Erika L.
P04.01 White Fibrous Papulosis of the Neck Maguire, Erin
P04.02 Segmental Stiff Skin Syndrome, a recently described clinical entity Powell, Julie
P05.01 Cutaneous Leishmaniasis Caused by Leishmania Infantum Acquired by a Child in Spain Grenier, Pierre-Olivier
P05.02 Co-infection of syphilis and HIV mimicking lymphoma: A case report and review of the literature To, Derek C.
P05.03 Costs, Outcomes, and Work-Related Factors of Occupational Cutaneous Infections in British Columbia Ogunyemi, Boluwaji
P05.04 Dermatophytosis as an uncommon, but easily treatable cause of unilateral external ear inflammation Christodoulou, George
P06.05 The Use of Minocycline in Promoting Secondary Intention Healing of Defects Following MOHS Micrographic Surgery Kossintseva, Irèn
P07.01 A case of amoxicillin-induced acute generalized exanthematous pustulosis presenting as septic shock McDonald, Katherine A.
P07.02 Recurrent Acute Generalized Exanthematous Pustulosis Secondary to Administration of Radiocontrast Medium Sutherland, Ashley E.
P07.03 Medical management of pediatric Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis Yu, Ashley M.
P07.04 Immediate-type infliximab infusion reaction presenting as purpura: A case report and review of the literature Soong, Laura C.
P08.01 Exaggerated Cutaneous Responses to Insect Bites in Three Patients with Chronic Lymphocytic Leukemia Mayba, Julia
P08.02 Ixekizumab Shows No Evidence for Reactivation of Previous or Latent Tuberculosis Infection in Psoriasis Patients : An Integrated Analysis of Seven Clinical Trials Guenther, Lyn
P08.03 Efficacy and Safety of Ixekizumab for the Treatment of Plaque Psoriasis: Results through 108 Weeks of a Randomized, Phase III Clinical Trial (UNCOVER-3) Gooderham, Melinda
P08.04 Incidence of Inflammatory Bowel Disease Among Ixekizumab-treated Patients with Plaque Psoriasis and Psoriatic Arthritis: Data from 8 Clinical Trials Adam, David N.
P08.05 Disseminated Eczema following Radiotherapy Cloutier-Bosworth, Alia
P08.06 A Case of Dyshidrotic Bullous Pemphigoid Basseri, Sana
P09.01 Calciphylaxis Following Spontaneous Tumor Lysis Syndrome in a Patient with Non-Hodgkin Lymphoma: Case Report and Literature Review Morand, Meggie
P09.02 Skin toxicity of temsirolimus  – a novel agent used in the treatment of malignant lung PEComa Doane, Jennifer A.
P09.03 Sweet’s Syndrome and Crohn’s Disease: A Unique Association Siedlikowski, Stefan
P10.01 Do Psoriasis Patients Who Participate in Clinical Research Differ from Those Who Do Not? Szeto, Vivian G.
P10.02 A rare entity: recurrent Pityriasis Rubra Pilaris MacGillivray, Megan E.
P10.03 The Effect of Comorbidities on Biologic Drug Survival in Psoriasis: a Systematic Review Mourad, Ahmed
P10.04 Efficacy and Safety of Apremilast Monotherapy in the Treatment of Moderate to Severe Plaque Psoriasis in the Real-World Setting: A Multicenter Retrospective Study Ighani, Arvin
P10.05 Pigmented Disseminated Superficial Actinic Porokeratosis in a Caucasian Patient, Case Report & Literature Review Sotoodian, Bahman
P11.01 An unusual case of basal cell carcinoma of a healthy mid-aged African-American woman Mireault, Julie
P11.02 Analysis of general population interest and seasonal and geographic trends in in skin cancers Toosi, Bez
P11.03 Melanoma in a solid organ transplant patient: Case study, review of the literature and proposed screening program in Toronto, ON Rosen, Cheryl
P11.04 Étude prospective de l’incidence des cancers cutanés au secteur de santé privé au Maroc Asbayo, Fatima
P11.05 ​Subcutaneous Sweet Syndrome: A Variant of Acute Febrile Neutrophilic Dermatosis or Neutrophilic Panniculitis? Wong, Noelle Y.
P12.01 Erythema nodosum as the initial presentation of nivolumab-induced sarcoidosis-like reaction Bourgeault, Emilie
P12.02 Efficacy of Topical Minoxidil 2 % Versus Topical Botanically Derived Inhibitors of 5α-reductase in Treatment of Female Pattern Hair Loss by Dermoscopy Abdelmaksoud, Rania E.
P12.03 Efficacy of PRP microneedling versus topical 5% minoxidil in the treatment of patterned hair loss Abdelmaksoud, Rania E.
P12.04 Topical Imiquimod Therapy for the Treatment of Nodular Basal Cell Carcinoma: A Comprehensive Review Huang, Christina M.
P12.05 Topical JAK Inhibition in Alopecia Areata: A Case of Treatment Failure and Review of JAK Inhibitor Successes Deeb, Maya
P12.06 Consistency of response across subgroups of patients with psoriasis treated with guselkumab: Results from the VOYAGE 1 and 2 trials Papp, Kim
P12.07 Children’s Hospital of Eastern Ontario (CHEO) Eczema Action Plan (EAP) Phase 2 (initial results): Assessing usability, satisfaction, usefulness & comprehension Shelley, Amanda
P12.08 The Role of Hypoglycemic Agents in the Treatment of Psoriasis Ip, Wilfred
P12.09 Angiolymphoid hyperplasia with eosinophilia – combination treatment with propranolol and surgical resection Ward, Chloe E.
P12.10 Efficacy of switching from ustekinumab to guselkumab in patients with moderate-to-severe plaque psoriasis: Results from the NAVIGATE study Langley, Richard G.
P12.11 Multiple warts: a pilot project for a novel treatment Khan, Kaleem J.
P13.01 Safety and tolerability of ixekizumab: integrated analysis of safety in patients with psoriasis with more than 7800 patient-years of exposure to ixekizumab Dickson, Ruth
P13.02 Interpretation of EASI-75 from a patient perspective – a post-hoc analysis from a phase 2b trial of dupilumab in adults with moderate-to-severe atopic dermatitis Poulin, Yves
P13.03 Efficacy and Safety of Adapalene 0.3% / Benzoyl Peroxide 2.5% Gel Plus Doxycycline in Subjects With Severe Inflammatory Acne (Non Nodulocystic) that are Candidates For Oral Isotretinion Gold, Linda Stein
P13.04 Atopic dermatitis from the patient’s perspective: Insights from text mining analysis of a cross-sectional study in US adults Arnold, Renée J.